Company Search:
Advanced Search
Sponsored Links
Surface Oncology Inc Company Snapshot
Surface Oncology Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Surface Oncology Inc with three other companies in this sector in UNITED STATES : Five Prime Therapeutics Inc (2019 sales of $14.87 million of which 100% was Clinical-stage biotechnology), Ascendis Pharma A/S ($14.95 million of which 74% was Revenue from rendering of services(Recog), and Arcus Biosciences Inc ($15.00 million of which 100% was Biopharmaceuticals).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Surface Oncology Inc
  Stock Performance Chart for Surface Oncology Inc
  Stock Data: Recent Stock Performance:
  Current Price (5/29/2020): 5.11
(Figures in U.S. Dollars)
1 Week -2.1%   13 Weeks 102.0%  
4 Weeks 61.7%   52 Weeks 40.0%  
Surface Oncology Inc Key Data:
  Ticker: SURF Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 15,360,000
(Year Ending Jan 2020).
Employees: 49
  Currency: U.S. Dollars Market Cap: 143,392,717
  Fiscal Yr Ends: December Shares Outstanding: 28,061,197
  Share Type: Common Closely Held Shares: 4,701,842
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.